Monthly Wegovy Costs vs Mounjaro: What You Need To Know
Can I Swap From Mounjaro To Wegovy? Understanding Monthly UK Costs
The decision to swap from Mounjaro to Wegovy requires careful consideration of both clinical factors and ongoing monthly expenses. Wegovy contains semaglutide, a GLP-1 receptor agonist, while Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors. Your monthly costs will vary significantly during the 16-week dose escalation period, starting at £79.99 for the initial 0.25mg dose and reaching £209.99 for the 2.4mg maintenance dose. This prescription-only medicine requires individual clinical assessment, as switching between different weight management treatments isn't automatically suitable for everyone.
Understanding the long-term financial commitment helps you budget effectively for your weight management journey. Unlike some competitors who hide pricing details, EverydayMeds provides transparent monthly costs with discount codes applied at checkout. The total annual cost at maintenance dose (2.4mg) amounts to approximately £2,520, though this calculation assumes you've completed the mandatory dose escalation protocol. Both treatments are available through our GPhC-registered pharmacy (#9012878), ensuring you receive expert guidance on which option best suits your clinical needs and budget requirements.
Wegovy Pricing Structure: Monthly Costs When Swapping From Mounjaro
When considering whether you can swap from Mounjaro to Wegovy, the monthly pricing structure follows a specific escalation pattern that cannot be bypassed. Your first month costs £79.99 for the 0.25mg starter dose, followed by £94.99 for the 0.5mg dose (weeks 5-8), then £99.99 for 1mg (weeks 9-12), and £139.99 for 1.7mg (weeks 13-16). The maintenance dose of 2.4mg costs £209.99 monthly from week 17 onwards. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to access these competitive prices.
Bundle options provide supply security rather than cost savings, with the Intro Duo (0.25mg and 0.5mg) priced at £169.99 for your first two months' supply. The Ultimate Stability Trio offers three months of maintenance supply at £649.99, ensuring uninterrupted treatment without monthly ordering requirements. This prescription-only medicine requires ongoing clinical monitoring, and our team ensures you understand both the immediate and long-term cost implications of switching from alternative treatments like Mounjaro.
Clinical Evidence Supporting Swapping From Mounjaro To Wegovy
Clinical trials demonstrate that Wegovy may support significant weight management outcomes when used alongside a reduced-calorie diet and increased physical activity. The STEP 1 trial (Wilding et al., NEJM, 2021) showed participants achieved an average of approximately clinically studied weight loss at 68 weeks compared to 2.4% with placebo. However, individual results vary considerably, and your prescriber must assess whether switching from Mounjaro to Wegovy aligns with your specific clinical profile and treatment goals.
The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events (HR 0.80) in adults with established cardiovascular disease, though this doesn't assurance similar outcomes for all patients. When considering whether you can swap from Mounjaro to Wegovy, your prescriber evaluates factors including previous treatment response, side effect profile, and individual medical history to determine the most appropriate option for your circumstances.
How Wegovy Works When Switching From Mounjaro
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural hormones involved in appetite regulation and glucose control. Unlike Mounjaro's dual GLP-1 and GIP receptor targeting, Wegovy works exclusively on GLP-1 receptors to reduce appetite and promote feelings of fullness after smaller meals. The medication may help reduce food cravings by acting on appetite centres in the brain, though individual responses vary significantly. This mechanism difference explains why some patients and prescribers consider switching between treatments based on efficacy and tolerability profiles. The once-weekly injection schedule remains consistent whether you're switching from Mounjaro or starting Wegovy as your first GLP-1 treatment, maintaining convenience for long-term weight management protocols.
Ordering Process When You Can Swap From Mounjaro To Wegovy
Accessing Wegovy through EverydayMeds involves a straightforward three-step process designed to ensure clinical safety and regulatory compliance. You complete a comprehensive 3-minute online clinical assessment that covers your medical history, current medications, and treatment goals, including previous experience with Mounjaro if applicable. Our registered prescribers review your assessment within 3 working days (or 24 hours with express service) to determine suitability for Wegovy treatment. Once approved, your prescription-only medicine is dispatched via next-day delivery using specialized cold-chain packaging to maintain the required 2-8°C temperature throughout transit. This process ensures you receive genuine, properly stored medication while meeting all MHRA regulatory requirements for prescription-only weight management treatments.
Storage and Practical Considerations for Wegovy vs Mounjaro
A key practical advantage when considering whether you can swap from Mounjaro to Wegovy relates to storage flexibility and travel convenience. Wegovy maintains stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more suitable for patients who travel frequently or prefer greater storage flexibility. The FlexTouch pen delivery system provides consistent, accurate dosing throughout the 16-week escalation protocol, starting at 0.25mg and progressing to the 2.4mg maintenance dose. Both treatments require refrigeration at 2-8°C before first use, but Wegovy's superior room temperature tolerance often influences prescriber recommendations for patients with active lifestyles or irregular schedules.
Monthly Budget Planning When Swapping From Mounjaro To Wegovy
Effective budget planning requires understanding the complete cost trajectory over your first year of treatment and beyond. Your initial four months cost £448.96 total (including the dose escalation from 0.25mg to 1.7mg), while months five through twelve at the maintenance 2.4mg dose cost £1,679.92. This brings your first-year total to approximately £2,128.88, assuming you complete the escalation protocol without delays or dose adjustments.
The DOSE25 discount code ensures returning customers maintain competitive pricing throughout their treatment journey, making long-term adherence more financially sustainable. Many patients find budgeting easier with bundle options like the Ultimate Stability Trio, which provides three months of maintenance supply for £649.99, reducing the frequency of transactions while ensuring uninterrupted treatment. When comparing whether you can swap from Mounjaro to Wegovy, consider both immediate monthly costs and annual expenditure to make an informed financial decision that supports long-term treatment success.
Start Your Wegovy Journey Today With EverydayMeds
Both Wegovy and Mounjaro are available through EverydayMeds, with our experienced clinical team helping determine which treatment best suits your individual needs and circumstances. New customers benefit from code FIRST40 applied at checkout, while returning customers use DOSE25 to access our competitive pricing structure. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine medication with proper cold-chain handling and expert clinical oversight throughout your treatment journey. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discover whether Wegovy represents the right choice for your weight management goals. Complete your assessment today to access this prescription-only medicine with the convenience, expertise, and ongoing support that makes successful long-term weight management achievable.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
